• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Theravance Inc. (THRX)

    -NasdaqGS
    15.32 Up 1.06(7.43%) 4:00PM EDT
    |After Hours : 15.32 0.00 (0.00%) 4:43PM EDT
    Add to Portfolio
    Prev Close:14.26
    Open:14.24
    Bid:15.31 x 1300
    Ask:15.32 x 200
    1y Target Est:16.00
    Beta:3.1
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:13.59 - 15.74
    52wk Range:10.58 - 23.84
    Volume:1,707,314
    Avg Vol (3m):578,331
    Market Cap:1.79B
    P/E (ttm):N/A
    EPS (ttm):-0.98
    Div & Yield:1.00 (6.20%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    THRXUp 7.43%1.79B
    AZNUp 0.15%42.71B
    PFEUp 0.92%222.05B

    Key Statistics

    Forward P/E (1 yr):33.30
    P/S (ttm):103.46
    Ex-Dividend Date:10-Jun-15

    Analysts

    Annual EPS Est (Dec-15) :-0.15
    Quarterly EPS Est (Sep-15) :-0.03
    Mean Recommendation*:3.2
    PEG Ratio (5 yr expected):0.57

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback